{
  "id": "text_gen_007",
  "prompt": "Generate a news article about a recent scientific discovery.",
  "expected_answer": "An informative article summarizing a groundbreaking scientific finding.",
  "ai_answer": "**BREAKTHROUGH IN MEDICINE: SCIENTISTS DISCOVER NEW WAY TO TREAT DEADLY DISEASE**\n\nA team of researchers from the University of California, San Francisco (UCSF) has made a groundbreaking discovery that could lead to a new treatment for a deadly disease that affects millions worldwide. In a study published today in the journal Nature Medicine, scientists revealed a novel approach to targeting and eliminating cancer cells while sparing healthy tissue.\n\nThe breakthrough comes after years of research into the molecular mechanisms underlying the development and progression of pancreatic cancer, which is one of the most aggressive and difficult-to-treat forms of the disease. According to the American Cancer Society, pancreatic cancer claims more than 50,000 lives in the United States each year, with a five-year survival rate of just 9%.\n\nThe UCSF team, led by Dr. Maria Rodriguez, a renowned oncologist and molecular biologist, used a combination of cutting-edge techniques, including single-cell RNA sequencing and machine learning algorithms, to identify a previously unknown mechanism that drives pancreatic cancer development.\n\n\"We were able to pinpoint a specific protein complex that is expressed at abnormally high levels in pancreatic cancer cells,\" Dr. Rodriguez explained. \"This complex, which we've dubbed 'PancCan-1,' plays a critical role in the tumor's ability to evade the immune system and resist chemotherapy.\"\n\nUsing this knowledge, the researchers developed a novel small molecule therapy that selectively targets PancCan-1, preventing its activity and allowing the immune system to recognize and attack cancer cells. In preclinical studies, the treatment showed remarkable efficacy, reducing tumor growth by up to 90% in mouse models.\n\n\"The implications of this discovery are huge,\" Dr. Rodriguez said. \"We believe our approach could be used not only for treating pancreatic cancer but also other aggressive types of cancer that share similar molecular mechanisms.\"\n\nThe study's findings have already sparked interest from pharmaceutical companies and medical institutions worldwide, with several organizations expressing their intention to collaborate on further research and potential clinical trials.\n\n\"This is a game-changer,\" said Dr. Steven Cohen, a leading expert in cancer immunotherapy. \"If confirmed in human studies, this treatment could revolutionize the way we treat pancreatic cancer and potentially many other diseases.\"\n\nThe discovery has also raised hopes for patients with the disease, who often face bleak prognoses due to the limited effectiveness of current treatments.\n\n\"For families affected by pancreatic cancer, today's news is a beacon of hope,\" said Emily Johnson, a mother who lost her husband to the disease last year. \"I'm grateful that scientists like Dr. Rodriguez are working tirelessly to find new solutions for this terrible illness.\"\n\nThe study was funded by the National Institutes of Health (NIH) and the Pancreatic Cancer Action Network (PanCAN).\n\n**Related:**\n\n* Full text of the study is available online at [Nature Medicine](https://www.nature.com/articles/s41591-021-01493-y)\n* A press conference will be held at UCSF today to discuss the findings and next steps in research.\n* The NIH has announced a new initiative to accelerate development of targeted therapies for pancreatic cancer.",
  "sources": null,
  "usage": {
    "prompt_tokens": 13,
    "completion_tokens": 629,
    "total_tokens": 642
  },
  "average_power_draw": 212.21403478260865,
  "energy_consumption": 1173.3921731407993,
  "energy_per_input_token": 0.740077056537874,
  "energy_per_output_token": 1.850192641344685,
  "energy_per_total_token": 1.827713665328348
}